Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cells

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 587-597

  Murakami, Yousuke ^a   Narayanan, Sriram ^a,d   Su, Su ^b   Childs, Richard ^b   Krzewski, Konrad ^a   Borrego, Francisco ^c   Weck, Jennifer ^a   Coligan, John E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CELL SURFACE RECEPTOR; FAS ANTIGEN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; PROTEIN TOSO; STAT5 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL SELECTION; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; HEK293 CELLS; HUMANS; INTERLEUKIN-2; JURKAT CELLS; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; RECEPTORS, FC; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84863609400     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200840     Document Type: Article

References (29)

1. Ramaswamy, M., C. Dumont, A. C. Cruz, J. R. Muppidi, T. S. Gomez, D. D. Billadeau, V. L. Tybulewicz, and R. M. Siegel. 2007. Cutting edge: Rac GTPases sensitize activated T cells to die via Fas. J. Immunol. 179: 6384-6388.
2. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448.
3. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267: 1449-1456.
4. Sytwu, H. K., R. S. Liblau, and H. O. McDevitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5: 17-30.
5. Van Parijs, L., and A. K. Abbas. 1996. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8: 355-361. (Pubitemid 26229657)
6. Vignaux, F., E. Vivier, B. Malissen, V. Depraetere, S. Nagata, and P. Golstein. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181: 781-786.
7. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348-351.
8. Lenardo, M. J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353: 858-861. (Pubitemid 21912642)
9. Ortaldo, J. R., A. T. Mason, and J. J. O'Shea. 1995. Receptor-induced death in human natural killer cells: involvement of CD16. J. Exp. Med. 181: 339-344.
10. Poggi, A., A. M. Massaro, S. Negrini, P. Contini, and M. R. Zocchi. 2005. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J. Immunol. 174: 2653-2660. (Pubitemid 40279679)
11. Yamauchi, A., K. Taga, H. S. Mostowski, and E. T. Bloom. 1996. Target cell-induced apoptosis of interleukin-2-activated human natural killer cells: roles of cell surface molecules and intracellular events. Blood 87: 5127-5135. (Pubitemid 26189853)
12. Hitoshi, Y., J. Lorens, S. I. Kitada, J. Fisher, M. LaBarge, H. Z. Ring, U. Francke, J. C. Reed, S. Kinoshita, and G. P. Nolan. 1998. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 8: 461-471. (Pubitemid 28196800)
13. Song, Y., and C. O. Jacob. 2005. The mouse cell surface protein TOSO regulates Fas/Fas ligand-induced apoptosis through its binding to Fas-associated death domain. J. Biol. Chem. 280: 9618-9626. (Pubitemid 40409658)
14. Shima, H., H. Takatsu, S. Fukuda, M. Ohmae, K. Hase, H. Kubagawa, J. Y. Wang, and H. Ohno. 2010. Identification of TOSO/FAIM3 as an Fc receptor for IgM. Int. Immunol. 22: 149-156.
15. Kubagawa, H., S. Oka, Y. Kubagawa, I. Torii, E. Takayama, D. W. Kang, G. L. Gartland, L. F. Bertoli, H. Mori, H. Takatsu, et al. 2009. Identity of the elusive IgM Fc receptor (FcmuR) in humans. J. Exp. Med. 206: 2779-2793.
16. Nguyen, X. H., P. A. Lang, K. S. Lang, D. Adam, G. Fattakhova, N. Föger, M. A. Kamal, P. Prilla, S. Mathieu, C. Wagner, et al. 2011. Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. Blood 118: 598-608.
17. Igarashi, T., J. Wynberg, R. Srinivasan, B. Becknell, J. P. McCoy, Jr., Y. Takahashi, D. A. Suffredini, W. M. Linehan, M. A. Caligiuri, and R. W. Childs. 2004. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood 104: 170-177. (Pubitemid 38879854)
18. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL- 7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679.
19. Kovanen, P. E., and W. J. Leonard. 2004. Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202: 67-83. (Pubitemid 39576905)
20. Bouillet, P., and L. A. O'Reilly. 2009. CD95, BIM and T cell homeostasis. Nat. Rev. Immunol. 9: 514-519.
21. Mitra, D. K., S. C. De Rosa, A. Luke, A. Balamurugan, B. K. Khaitan, J. Tung, N. K. Mehra, A. I. Terr, A. O'Garra, L. A. Herzenberg, and M. Roederer. 1999. Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseases. Int. Immunol. 11: 1801-1810. (Pubitemid 29533095)
22. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
23. Vire, B., A. David, and A.Wiestner. 2011. TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation. J. Immunol. 187: 4040-4050.
24. Watson, S. P., J. M. Herbert, and A. Y. Pollitt. 2010. GPVI and CLEC-2 in hemostasis and vascular integrity. J. Thromb. Haemost. 8: 1456-1467.
25. Mourão-Sá, D., M. J. Robinson, S. Zelenay, D. Sancho, P. Chakravarty, R. Larsen, M. Plantinga, N. Van Rooijen, M. P. Soares, B. Lambrecht, and C. Reis e Sousa. 2011. CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur. J. Immunol. 41: 3040-3053.
26. Engels, N., and J. Wienands. 2011. The signaling tool box for tyrosine-based costimulation of lymphocytes. Curr. Opin. Immunol. 23: 324-329.
27. Spreu, J., S. Kuttruff, V. Stejfova, K. M. Dennehy, B. Schittek, and A. Steinle. 2010. Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes. Proc. Natl. Acad. Sci. USA 107: 5100-5105.
28. Carpenter, G., and Q. Ji. 1999. Phospholipase C-gamma as a signal-transducing element. Exp. Cell Res. 253: 15-24.
29. Sorkin, A., and M. von Zastrow. 2009. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10: 609-622.